Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile-associated Diarrhea (CDAD)”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Not applicableUnknownNCT03141775
What this trial is testing

Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Diarrhea
University of Cologne 541
Testing effectiveness (Phase 2)Study completedNCT00034294
What this trial is testing

GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile Diarrhea+2 more
Genzyme, a Sanofi Company 300
Large-scale testing (Phase 3)Study completedNCT01983683
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 631
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Testing effectiveness (Phase 2)Study completedNCT00097422
What this trial is testing

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Not applicableLooking for participantsNCT06839209
What this trial is testing

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium; Difficile, As Cause of Disease Classified ElsewhereClostridium Difficile Diarrhea
ABResearch S.r.l. 18
Not applicableUnknownNCT02681068
What this trial is testing

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

Who this might be right for
Clostridium Infections
University of Cologne 1,000
Testing effectiveness (Phase 2)Study completedNCT01559545
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Who this might be right for
Clostridium Difficile Associated Diarrhea
Dr. Reddy's Laboratories Limited 60
Testing effectiveness (Phase 2)Study completedNCT01222702
What this trial is testing

Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile Infection
Actelion 84
Post-approval studies (Phase 4)Ended earlyNCT04003818
What this trial is testing

Efficacy and Safety of Teicoplanin in CDAD

Who this might be right for
Clostridium Difficile Infection-associated Diarrhea and Colitis
Sanofi 50
Large-scale testing (Phase 3)Study completedNCT00106509
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisPseudomembranous Colitis
Genzyme, a Sanofi Company 520
Large-scale testing (Phase 3)Study completedNCT02179658
What this trial is testing

Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile
Astellas Pharma Inc 210
Large-scale testing (Phase 3)Study completedNCT01987895
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 632
Large-scale testing (Phase 3)Study completedNCT00196794
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisDiarrhea
Genzyme, a Sanofi Company 520
Large-scale testing (Phase 3)Study completedNCT02218372
What this trial is testing

Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
Astellas Pharma Europe B.V. 148
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Not applicableStudy completedNCT01401023
What this trial is testing

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
DiarrheaClostridium Difficile
Gary E. Stein, Pharm.D. 10
Large-scale testing (Phase 3)Study completedNCT00958308
What this trial is testing

Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection

Who this might be right for
Antibiotic-Associated DiarrheaClostridium Difficile-Associated Diarrhea
Bio-K Plus International Inc. 255
Load More Results